HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence

Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:	Thomas Clausen, MD - Oslo, Norway Pier Paolo Pani, MD - Cagliari, Italy, EU Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:	Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by article

Browse by volume

Heroin Addiction and Related Clinical Problems: 2001, 03, 1 (pages: 7 - 12)

The promise of opioid receptor antagonist drugs in the treatment of neuropsychiatric disorders

Deltito J., Maremmani I.

Summary: The endogenous opioid system, either directly or through its influence on other neurotransmitter systems, has far-reaching effects on normal as well as abnormal (maladaptive) behaviours, thoughts and mood states. Altering this system through the use of an opioid antagonist medication may not only be useful in treating recognized psychiatric illnesses, but may also prove to be valuable in elucidating psychophysiological abnormalities that could contribute to the foundation of these disorders.

Reader login

Author login

AU-CNS Associazione per l’Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 – 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 – Codice Fiscale 94002580465

Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org

HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS

The official journal of EUROPAD - European Opiate Addiction Treatment Association WFTOD - World Federation for the Treatment of Opioid Dependence

Editor: Icro Maremmani, MD - Pisa, Italy, EU

Associate Editors:

Thomas Clausen, MD - Oslo, Norway Pier Paolo Pani, MD - Cagliari, Italy, EU Marta Torrens, MD - Barcelona, Spain, EU

Statistical Editor:

Mario Miccoli, PhD - Pisa, Italy, EU